The human tripeptide GHK-Cu in the prevention of oxidative stress and degenerative conditions of aging
Regulatory Status None of GLOW Blend's three components GHK-Cu, BPC-157, or TB-500 is approved by the FDA as a drug for any indication
This makes it a powerful tool i
No serious adverse events, hospitalization, organ damage, death, have been documented in any published BPC-157 research
How Its Administered Subcutaneous (SubQ): Injected into belly fat or a fatty tissue area for systemic distribution Intramuscular (IM): Injected directly into or near an injured muscle or tendon for localized healing Dosage: Typically 250500 mcg daily, often split into two doses depending on severity Injectable BPC157 is typically sold as a lyophilized powder, reconstituted with bacteriostatic water and drawn into an insulin syringe for injection
If you want to build a multi-compound approach, cagrilintide is the more flexible building block